Table 2 Quality assessment of each study included in this systematic review by using the modified QUADAS questionnaire
From: Blood and CSF biomarkers for post-stroke epilepsy: a systematic review
Study | All patients had same reference standard test | All patients had reference standard whether BM+/BM- | Biomarker status not part of epilepsy diagnosis | Biomarker measurement blind to stroke status | Clinical/Radiology opinion blind to biomarker status | All the patients who entered the study had results reported | Diagnostic threshold established before study |
|---|---|---|---|---|---|---|---|
Zhang et al. 2014 (China) [7] | 1 | 1 | 1 | 0 | 1 | 1 | 0 |
Abraira et al. 2020 (Spain) [8] | 1 | 1 | 1 | 0 | 1 | 1 | 0 |
Zhang et al. 2020 (China) [9] | 1 | 1 | 1 | 0 | 1 | 1 | 0 |
Fu et al. 2109 (China) [10] | 1 | 1 | 1 | 0 | 1 | 1 | 0 |
Eriksson et al. 2019 (U.K [11] | 1 | 1 | 1 | 0 | 1 | 1 | 0 |
Jia et al. 2020 (China) [12] | 1 | 1 | 1 | 0 | 1 | 1 | 0 |
Yang et al. 2014 (China) [13] | 1 | 1 | 1 | 0 | 1 | 1 | 0 |
Wang et al. 2021 (China) [14] | 1 | 1 | 1 | 0 | 1 | 1 | 0 |